Marini, E.; Marino, M.; Gionfriddo, G.; Maione, F.; Pandini, M.; Oddo, D.; Giorgis, M.; Rolando, B.; Blua, F.; Gastaldi, S.;
et al. Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein. Molecules 2022, 27, 8513.
https://doi.org/10.3390/molecules27238513
AMA Style
Marini E, Marino M, Gionfriddo G, Maione F, Pandini M, Oddo D, Giorgis M, Rolando B, Blua F, Gastaldi S,
et al. Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein. Molecules. 2022; 27(23):8513.
https://doi.org/10.3390/molecules27238513
Chicago/Turabian Style
Marini, Elisabetta, Marco Marino, Giulia Gionfriddo, Federica Maione, Marta Pandini, Daniele Oddo, Marta Giorgis, Barbara Rolando, Federica Blua, Simone Gastaldi,
and et al. 2022. "Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein" Molecules 27, no. 23: 8513.
https://doi.org/10.3390/molecules27238513
APA Style
Marini, E., Marino, M., Gionfriddo, G., Maione, F., Pandini, M., Oddo, D., Giorgis, M., Rolando, B., Blua, F., Gastaldi, S., Marchiò, S., Kovachka, S., Spyrakis, F., Gianquinto, E., Di Nicolantonio, F., & Bertinaria, M.
(2022). Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein. Molecules, 27(23), 8513.
https://doi.org/10.3390/molecules27238513